BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22811823)

  • 1. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma.
    Saglam S; Aykan NF; Sakar B; Gulluoglu M; Balik E; Karanlik H
    J Gastrointest Oncol; 2011 Mar; 2(1):19-26. PubMed ID: 22811823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
    Kim SJ; Seo HY; Choi JG; Sul HR; Sung HJ; Park KH; Choi IK; Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):436-42. PubMed ID: 16049620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot Study of Heptaplatin, UFT-E and Leucovorin in Advanced Gastric Carcinoma.
    Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim SY; Yoon HJ; Cho KS; Kim JS
    Cancer Res Treat; 2003 Apr; 35(2):117-22. PubMed ID: 26680924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
    Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer.
    Koinumaru S; Matsuda T; Saitoh J; Nakai Y
    Lung Cancer; 1997 Nov; 18(3):241-51. PubMed ID: 9444649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients.
    Somali I; Meydan N; Tarhan MO; Oztop I; Alacacioglu A; Yilmaz U
    J BUON; 2009; 14(3):429-33. PubMed ID: 19810134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of epirubicin plus oxaliplatin and fluorouracil as first-line chemotherapy for advanced gastric cancer.
    Zhao JG; Xiong JP; Xiang XJ; Qiu F; Zhang L; Yu F
    Ai Zheng; 2009 Jan; 28(1):42-4. PubMed ID: 19448415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
    Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.
    Choi IK; Seo HY; Sung HJ; Park KH; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Med Oncol; 2007; 24(1):33-7. PubMed ID: 17673809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
    J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancer.
    Seymour MT; Dent JT; Papamichael D; Wilson G; Cresswell H; Slevin ML
    Ann Oncol; 1999 Nov; 10(11):1329-33. PubMed ID: 10631461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of Oral UFT and leucovorin in advanced gastric carcinoma.
    Kim YH; Cheong SK; Lee JD; Park JS; Shin SW; Kim JS
    Am J Clin Oncol; 1996 Apr; 19(2):212-6. PubMed ID: 8610653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and UFT modulated with leucovorin for the treatment of Advanced non-small-cell lung cancer.
    Feliu J; Gonzalez-Baron M; Espinosa E; de Castro J; Ordonez A; Zamora P; Gomez-Navarro J; Espinosa J; Vilches Y; de la Gandara I
    Am J Clin Oncol; 1996 Apr; 19(2):121-4. PubMed ID: 8610633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
    González Barón M; Espinosa E; Feliu J; Ordóñez A; Zamora P; de Castro J; García Girón C; García Alfonso P; Garrido P; Belón J; Lomas M
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):109-12. PubMed ID: 9348581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of cisplatin, irinotecan, leucovorin and 5-fluorouracil (PILF) combination chemotherapy for advanced gastric cancer.
    Park SH; Jeon SY; Ko KI; Nam E; Bang SM; Cho EK; Shin DB; Lee JH; Lee WK; Chung M
    Cancer Res Treat; 2006; 38(3):121-5. PubMed ID: 19771271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
    Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer; 2005 Jun; 103(11):2338-43. PubMed ID: 15825161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.